方敏

課題項目：長鏈非編碼RNAAFAP1-AS1通過穩(wěn)定YAP促進(jìn)鼻咽癌發(fā)生發(fā)展的機制，省部級；Opal/TSA多標(biāo)記免疫熒光技術(shù)檢測三陰乳腺癌組織免疫細(xì)胞表達(dá)譜及臨床應(yīng)用，廳局級。論文發(fā)表：LongNoncodingRNAAFAP1-AS1IsaCriticalRegulatorofNasopharyngealCarcinomaTumorigenicity，F(xiàn)rontiersinOncology，2020/11/23，IF：6.244；DoseEscalationinEsophagealCancer，InternationalJournalofRadiationOncologyBiologyPhysics，2017/04/16，IF：5.554；Comparativestudyofcisplatin-baseddefinitiveconcurrentchemoradiotherapywithS-1versuspaclitaxelforunresectablelocallyadvancedesophagealsquamouscellcarcinoma.，Oncotarget，2017/03/14，IF：5.168；Pretreatmentnutritionalriskscoresandperformancestatusareprognosticfactorsinesophagealcancerpatientstreatedwithdefinitivechemoradiotherapy.，Oncotarget，2017/10/19，IF：5.168；Multimodaltreatmentbasedonthyroidectomyimprovessurvivalinpatientswithmetastaticanaplasticthyroidcarcinoma：aSEERanalysisfrom1998to2015，GlandSurgery，2020/09/10，IF：3.0。

擅長乳腺癌、肺癌等常見胸部腫瘤、頭頸部腫瘤的放化療及綜合治療